About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial
April 17, 2015
click here to read more
Post navigation
Previous Post
Phosphagenics Appoints Three New Directors
Next Post
Appendix 3X Notices – Three New Directors
Related Posts
Receipt of R&D Tax Incentive
November 27, 2018
Phosphagenics Mylan Arbitration Hearing Concluded
November 9, 2017
$5.06m Placement Complete
February 9, 2021
February 23, 2021